ClinicalTrials.gg
Drug

Mitoxantrone clinical trials

Also written Novantrone, CL 232315 and Mitozantrone.

Includes 34 studies of Liposomal Mitoxantrone Hydrochloride and 3 studies of Pegylated Liposomal Mitoxantrone Hydrochloride.

studies test it
165
open now
19
in phase 3
19
first study started
1991

How each study uses Mitoxantrone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Mitoxantrone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
23 Dec 1987 · NOVANTRONE · NDA 019297 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

mitoxantrone hydrochloride
64
Mitoxantrone
48
DHAD
12
DHAQ
12
Dihydroxyanthracenedione
6

Brand

Novantrone
33

Development codes

CL 232315
12
NSC-301739
1

Other names

Mitozantrone
9

Studies by the year they started

162 studies that test it; most in 2021 (12)

Studies that test Mitoxantrone, by start year
YearStudies
19911
19921
19931
19943
19952
19963
19976
19983
19995
20002
20016
20024
20034
20046
20057
20067
20073
20084
20096
20106
20116
20126
20133
20142
20155
20169
20171
20185
20192
20206
202112
20227
20237
20248
20263

Who runs them

Industry 35 · Other 130

CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (22) · National Cancer Institute (NCI) (13) · Fred Hutchinson Cancer Center (8) · M.D. Anderson Cancer Center (6) · Institute of Hematology & Blood Diseases Hospital, China (6) · University of Washington (5) · Memorial Sloan Kettering Cancer Center (4) · St. Jude Children's Research Hospital (3)

Often tested with

Tested in the same studies.

Cytarabine (48) · Etoposide (35) · Cyclophosphamide (18) · Rituximab (18) · Prednisone (16) · Cladribine (15) · Fludarabine (12) · Vincristine (11)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 2 phase 3 studies under way

Mitoxantrone is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 6

Studies that test Mitoxantrone.

Studies

Open first, then newest update. How each study uses Mitoxantrone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 165

See all 165 studies that test Mitoxantrone →

Given beside what is tested · 76 — Mitoxantrone is usual care or a partner of the new treatment

Showing 20 of 76.

As the comparator · 13 — what is tested is compared with Mitoxantrone

Codes

What other systems call Mitoxantrone · ClinicalTrials.gg INT007848

  • MeSH (NLM) D008942MitoxantroneConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) BZ114NVM5PMITOXANTRONEConfirmed FDA, NLM, Wikidata
  • RxNorm 7005Confirmed FDA, Wikidata
  • Wikidata Q239426mitoxantroneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C62050MitoxantroneOne source FDA
  • DrugBank DB01204One source Wikidata

Also registered as mitoxantrone hydrochloride (UNII U6USW86RD0 · RxNorm 203129).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.